Pathstone Holdings »

Genes shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Genes (GCO) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $589k 22k 27.16
2024-06-30 $457k 18k 25.88
2024-03-31 $398k 14k 28.14

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Coca-Cola Company (KO)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Genes

Pzena Investment Management
BlackRock
BlackRock
Alliancebernstein
Dimensional Fund Advisors
Vanguard Group
D. E. Shaw & Co
Acadian Asset Management
Marshall Wace
State Street Corporation
Arrowstreet Capital, Limited Partnership
Jpmorgan Chase & Co
Geode Capital Management
Charles Schwab Investment Management
American Century Companies

View all funds holding Genes